The introduction of new drugs that combat disease and infection at the genetic level has been a landmark breakthrough, both for laboratory science as well as for patient treatment plans. Cell-based therapeutics, on the other hand, stand to become influential in the coming years. A recent story from Newswise reported cell therapy as the next ...

It seems like bees have been all over the news lately. Even if a story isn’t directly about them, it somehow seems to find a way to relate. A recent story from Newswise cited the similarities between honey bees and human T-cells, which have apparently been taking some tips from the hive. When faced with a potential threat, our immune cells ...

I was catching up on recent coverage from some of our sister publications today, when this article from ADVANCE for Nurses caught my attention. Advances in medicine have, undoubtedly, extended our longevity. In ICUs, this means fungal infections may have more time to gain a stronghold in immunocompromised patients. Brenda Shelton, ...

Here's a great article from The New York Times featuring the lab and H1N1 testing. The story says rapid tests for H1N1 fail to properly detect infections more than half the time. Have you been finding this is true for your laboratory?

In an interview with Federal News Radio in March, Tara O’Toole, MD, MPH, was asked what she would tell President Obama if she had the chance. Her reply: ''There is a possibility, a real possibility, that there could be the equivalent of a bio-Katrina on his watch.'' Later, the Obama Administration nominated Dr. O'Toole to serve as under ...

One of today's ASM Award Lectures was the Maurice Hilleman Merck Award, presented to Stanley A. Plotkin, Sanofi Pasteur, Doylestown, PA. Maurice Hilleman is known for having developed more than 40 vaccines and is credited with having saved more lives than any other scientist in the 20th century. A memorial video about Dr. Hilleman showed newspaper ...